Newsmeme!
Discover News you didn't know existed
Even Hippocrates used willow bark to help ease back pain.
MONASH University and Sunway Medical Centre are offering to collaborate with government research institutions to jointly implement clinical trials in cancer research.
BECAUSE existing stocks are unlikely to meet the demand, the World Health Organization is stocking up on antivirals and antibiotics. ...
Heart patients over the age of 70 have often been excluded from clinical trials, sometimes based only on their age, but a U.S. study released last week has established that patients over the age of 70 can benefit from some of the same treatments as younger patients.
THE dengue season is again upon us and the Department of Health (DOH) has dutifully raised the alarm again. The warning is strangely muted. The press continues reflexively to describe the A(H1N1) virus “deadly” but no such adjective is attached to the dengue virus.
BECAUSE existing stocks “are unlikely to meet the demand,” the World Health Organization is stocking up on antivirals and antibiotics. The goal this year is an eventual vaccine that is accessible and affordable, especially in poor countries.
Designer Leah Heiss doesn't just want to make you look good. She wants you to feel good at the same time.
Genentech, Inc. announced today that the Phase III study BRAVO showed Lucentis® (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion.
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that their marketing authorization application for ONGLYZA™ (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of type 2 diabetes in adults as add-on therapy with metformin, a thiazolidinedione or a sulphonylurea.
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced results of a study demonstrating that TYSABRI® (natalizumab) promoted regeneration and stabilization of damage done to the myelin sheath, as measured by advanced MRI technology. Damage to the myelin sheath causes the symptoms of multiple sclerosis (MS).
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |